Omeprazole use in horses
Pro Research Analysisby 
Searched over 200M research papers
Omeprazole Use in Horses: Efficacy and Indications
Omeprazole is widely recognized as the primary treatment for equine gastric ulcer syndrome (EGUS), a condition highly prevalent in performance and racehorses. Studies consistently show that omeprazole, particularly in oral paste form at a dose of 4 mg/kg once daily, is highly effective in healing gastric ulcers, with 77% of treated horses experiencing complete healing and 92% showing significant improvement after 28 days of treatment. In contrast, untreated horses rarely show spontaneous healing of ulcers. Continued use of either a full or half dose helps prevent recurrence of ulcers, while stopping treatment can lead to a return of ulceration .
Omeprazole for Prevention of Gastric Ulcers in Training Horses
Meta-analyses of randomized controlled trials confirm that prophylactic use of omeprazole significantly reduces the occurrence and severity of gastric ulcers in horses undergoing active training. Horses receiving omeprazole prophylaxis had a much lower risk of developing ulcers compared to those given a placebo (23.4% vs. 77.2%). Both 1 mg/kg and 2 mg/kg doses were effective, with higher doses providing slightly greater reduction in ulcer severity .
Formulations and Dosing Considerations
Both gastroenteric-resistant granules and powder paste formulations of omeprazole are similarly effective in treating equine squamous gastric disease (ESGD), though glandular ulcers tend to respond less well to omeprazole treatment . The efficacy of omeprazole in raising gastric pH and suppressing acidity is influenced by both dose and diet. Higher doses (4 mg/kg) and high-grain/low-fiber diets enhance the drug’s effect, while hay-based diets may reduce its efficacy. This suggests that dosing recommendations should consider the horse’s diet for optimal results .
Safety and Long-Term Use of Omeprazole in Horses
Long-term use of omeprazole in horses is generally considered safe, with no clear evidence linking it to increased fracture risk as seen in humans. However, there is some evidence of potential issues such as rebound gastric hyperacidity after discontinuation, decreased calcium absorption, and possible disruption of hindgut function, especially when used with non-steroidal anti-inflammatory drugs (NSAIDs). There is also limited evidence that the drug’s efficacy may decrease with prolonged use . Studies specifically examining bone health found no negative effects on skeletal indices or mineral absorption after eight weeks of daily omeprazole administration .
Omeprazole and NSAID Use
When omeprazole is used alongside NSAIDs like phenylbutazone, it can help reduce the severity of glandular gastric lesions. However, this combination may increase the risk of intestinal complications, so caution is advised when co-prescribing these medications, especially during changes in management or feeding . In experimental models simulating fasting and NSAID administration, omeprazole was more effective than sucralfate in reducing the severity of gastric lesions .
Regulatory and Ethical Considerations in Competition
There is ongoing debate about the use of omeprazole during equestrian competitions. Recent evidence suggests that stopping omeprazole two days before competition can lead to recurrence of ulcers, while withholding only on the day of competition does not. This has led to calls for regulatory bodies to reconsider current rules to better protect horse welfare . Additionally, new long-acting injectable formulations of omeprazole have been developed, but their prolonged detection times make them unsuitable for use in horses actively in training under current racing regulations .
Conclusion
Omeprazole is a highly effective and generally safe treatment for preventing and healing gastric ulcers in horses, especially those in training or under stress. Its efficacy depends on dose, formulation, and diet, and it is superior to other anti-ulcer medications like sucralfate in certain scenarios. While long-term use appears safe, careful consideration is needed when combining with NSAIDs or managing withdrawal before competition. Ongoing research and regulatory review are important to ensure optimal horse welfare and effective ulcer management.
Sources and full results
Most relevant research papers on this topic